Skip to main content
Clinical Trials/NCT06072508
NCT06072508
Recruiting
Not Applicable

Prognostic Interest of Vasorin in Septic Shock

Centre Hospitalier Universitaire, Amiens1 site in 1 country50 target enrollmentJuly 3, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis
Sponsor
Centre Hospitalier Universitaire, Amiens
Enrollment
50
Locations
1
Primary Endpoint
correlation between vasorin concentration at day 3 and mortality rate
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

In septic shock, the intensity and duration of low blood pressure can lead to a critical reduction in renal tissue perfusion and lead to the onset of more or less severe Acute Kidney Injury (AKI). Vasorin (Vasn) is a protein strongly expressed in large vessels and kidneys, whose functions are still poorly known. Previous experimental studies show that Vasn is associated with decreased Angiotensin II concentrations, a vessel contractility defect and early mortality.

The investigators hypothesize that Vasn (the potential direct regulator of blood pressure) would be an early biomarker predicting the severity of AKI post septic shock, which may be associated with mortality from septic shock or lead to longer-term Chronic Renal Failure (CKD).

Registry
clinicaltrials.gov
Start Date
July 3, 2023
End Date
March 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age ≥18 years old.
  • Hospitalized in intensive care or medical resuscitation units.
  • With a septic shock state defined by 2 mmol/l lactate sepsis, requiring vasopressors to maintain mean blood pressure 65 mmHg (despite adequate vascular filling).
  • Whether or not they have developed AKI.
  • Patient/family information and collection of non opposition

Exclusion Criteria

  • Patients with chronic respiratory failure.
  • Pregnant women.
  • Patients in palliative care.
  • Information for the patient/someone close and collection of his opposition

Outcomes

Primary Outcomes

correlation between vasorin concentration at day 3 and mortality rate

Time Frame: day 3

correlation between vasorin concentration at day 0 and mortality rate

Time Frame: day 0

Study Sites (1)

Loading locations...

Similar Trials